Risperidone appears to be a significant advance in the treatment of schizophrenia. Its effectiveness for other serious psychiatric conditions, such as schizoaffective disorder and manic-depressive illness, has not been systematically studied. Further research is also needed to examine whether risperidone will be beneficial and adequately tolerated in special patient populations, including adolescents, the elderly, and psychiatric patients with concomitant medical illnesses.
Abstract Teaser